Zafer Saad Alshehri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zafer Saad Alshehri has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Faez Falah Alshehri
Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Ad Dawadimi, Saudi Arabia
3 shared publications- Faez Falah Alshehri
Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Aldawadmi, Saudi Arabia
2 shared publications - Abdulaziz Alkhoshaiban
Unit of Scientific Research, Applied College, Qassim University, Saudi Arabia
1 shared publication Abdullah D. Alanazi
Department of Biological Sciences, Faculty of Science and Humanities, Shaqra University, Ad-Dawadimi, Saudi Arabia
1 shared publication- Abdullah D. Alanazi
Department of Biological Sciences, Faculty of Science and Humanities, Shaqra University, Ad-Dawadimi, Saudi Arabia
1 shared publication - Abdur Rehman
Department of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad 38000, Pakistan
1 shared publication
Latest Publications
- 17 June 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (6) , 612
Structure-Based Discovery of Dual PD-L1 and IDO1 Small-Molecule Inhibitors for Non-Small Cell Lung Cancer
- 17 June 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (6) , 612
Structure-Based Discovery of Dual PD-L1 and IDO1 Small-Molecule Inhibitors for Non-Small Cell Lung Cancer
- 22 September 2025
- Published by Elsevier in Neuroscience
- Vol. 586, 44-57
Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer’s diseases
- 22 September 2025
- Published by Elsevier in Neuroscience
- Vol. 586, 44-57
Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer’s diseases
- 14 July 2025
- Published by Springer Nature in Acta Parasitologica
- Vol. 70 (4) , 1-11
Potential Therapeutic Effects of Isopropyltoluene (P-Cymene) Against Toxoplasma gondii Infection in Dexamethasone-Immunosuppressed Mice
Background Toxoplasmosis is a potentially life-threatening opportunistic infection that primarily affects individuals with weakened immune systems. Given the pharmacological characteristics of p-Cymene (p-isopropyltoluene, CM), the present experimental study was undertaken to evaluate the therapeutic effects and possible mechanisms of action of CM against Toxoplasma gondii infection in immunocompromised mice. Methods BALB/c mice, rendered immunocompromised through dexamethasone treatment and subsequently infected with the T. gondii ME49 strain. Then, mice received CM at doses of 5 and 10 mg/kg, either as a monotherapy or in conjunction with pyrimethamine (PYM, 10 mg/kg), over a two-week period. The investigation involved the assessment of various parasitological parameters such as the number and dimensions of T. gondii cysts and tissue levels of oxidant and antioxidant markers such as malondialdehyde (MDA), glutathione peroxidase (GPx), and superoxide dismutase (SOD) in the brain of the tested mice. In addition, the gene expression level of immune responses related cytokines (IFN-γ, IL-4, and IL-12) as well as apoptosis (Caspase-3, Bcl-2, and BAX) and pathogenesis-related genes (BAG1) were analyzed using quantitative reverse transcription polymerase chain reaction (Real-time-PCR). Results The administration of CM, particularly in conjunction with PYM, resulted in a significant (p < 0.001) reduction in the number and size of brain Toxoplasma cysts. This treatment also significantly reduced the tissue level of MDA (p < 0.001), whereas markedly increased the activities of antioxidant enzymes of GPx and SOD (p < 0.001). CM at the dose of 10 mg/kg mainly in combination with PYM significantly (p < 0.001) upregulated the expression levels of IFN-γ (5.23-fold change), IL-12 (4.33-fold change), Caspase-3 (3.3-fold change), and BAX (4.21-fold change); whereas, obviously (p < 0.001) downregulated the expression of IL-4 (1.10-fold change), Bcl-2 (1.09-fold change), and BAG1 (1.28-fold change). Following treatment with CM, particularly the combinations of PYM at 10 mg/kg over a 14-day period, there was a marked modulation of serum levels of AST, ALT, BUN, and Cr in the IC-infected mice. Post hoc analysis indicated no significant differences in the serum levels of liver and kidney function biomarkers between healthy mice treated with CM at doses of 5 and 10 mg/kg and the control group of healthy mice that received normal saline. Conclusion The findings of this survey indicate that CM alone and in combination with PYM demonstrates significant efficacy in treating chronic toxoplasmosis in mice with dexamethasone-induced immunosuppression. The results suggest that potential mechanisms for managing latent toxoplasmosis may include the regulation of oxidative stress, enhancement of antioxidant enzyme activity, induction of apoptosis, and modulation of inflammatory responses, all while maintaining the functionality of vital organs without toxicity. To further substantiate the therapeutic potential of this compound, it is imperative to conduct clinical trials that evaluate both its toxicity and therapeutic efficacy.
- 14 July 2025
- Published by Springer Nature in Acta Parasitologica
- Vol. 70 (4) , 1-11
Potential Therapeutic Effects of Isopropyltoluene (P-Cymene) Against Toxoplasma gondii Infection in Dexamethasone-Immunosuppressed Mice
Background Toxoplasmosis is a potentially life-threatening opportunistic infection that primarily affects individuals with weakened immune systems. Given the pharmacological characteristics of p-Cymene (p-isopropyltoluene, CM), the present experimental study was undertaken to evaluate the therapeutic effects and possible mechanisms of action of CM against Toxoplasma gondii infection in immunocompromised mice. Methods BALB/c mice, rendered immunocompromised through dexamethasone treatment and subsequently infected with the T. gondii ME49 strain. Then, mice received CM at doses of 5 and 10 mg/kg, either as a monotherapy or in conjunction with pyrimethamine (PYM, 10 mg/kg), over a two-week period. The investigation involved the assessment of various parasitological parameters such as the number and dimensions of T. gondii cysts and tissue levels of oxidant and antioxidant markers such as malondialdehyde (MDA), glutathione peroxidase (GPx), and superoxide dismutase (SOD) in the brain of the tested mice. In addition, the gene expression level of immune responses related cytokines (IFN-γ, IL-4, and IL-12) as well as apoptosis (Caspase-3, Bcl-2, and BAX) and pathogenesis-related genes (BAG1) were analyzed using quantitative reverse transcription polymerase chain reaction (Real-time-PCR). Results The administration of CM, particularly in conjunction with PYM, resulted in a significant (p < 0.001) reduction in the number and size of brain Toxoplasma cysts. This treatment also significantly reduced the tissue level of MDA (p < 0.001), whereas markedly increased the activities of antioxidant enzymes of GPx and SOD (p < 0.001). CM at the dose of 10 mg/kg mainly in combination with PYM significantly (p < 0.001) upregulated the expression levels of IFN-γ (5.23-fold change), IL-12 (4.33-fold change), Caspase-3 (3.3-fold change), and BAX (4.21-fold change); whereas, obviously (p < 0.001) downregulated the expression of IL-4 (1.10-fold change), Bcl-2 (1.09-fold change), and BAG1 (1.28-fold change). Following treatment with CM, particularly the combinations of PYM at 10 mg/kg over a 14-day period, there was a marked modulation of serum levels of AST, ALT, BUN, and Cr in the IC-infected mice. Post hoc analysis indicated no significant differences in the serum levels of liver and kidney function biomarkers between healthy mice treated with CM at doses of 5 and 10 mg/kg and the control group of healthy mice that received normal saline. Conclusion The findings of this survey indicate that CM alone and in combination with PYM demonstrates significant efficacy in treating chronic toxoplasmosis in mice with dexamethasone-induced immunosuppression. The results suggest that potential mechanisms for managing latent toxoplasmosis may include the regulation of oxidative stress, enhancement of antioxidant enzyme activity, induction of apoptosis, and modulation of inflammatory responses, all while maintaining the functionality of vital organs without toxicity. To further substantiate the therapeutic potential of this compound, it is imperative to conduct clinical trials that evaluate both its toxicity and therapeutic efficacy.
- Open Access
- 8 July 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1587224
Immuno-informatics analyses of important esophageal cancer associated viruses for multi-epitope vaccine design
Introduction: Esophageal cancer (EC) is a highly lethal malignancy characterized by the uncontrolled proliferation of cancerous cells within the esophagus. Despite recent advancements in therapeutic strategies, the prognosis remains poor, underscoring the urgent need for novel preventive and therapeutic approaches. Notably, several oncogenic viruses have been implicated in EC pathogenesis, prompting the exploration of epitope-based vaccines through immunoinformatics.Methods: Using immunoinformatics and bioinformatics approaches, we designed a novel multi-epitope vaccine targeting viral agents associated with EC. Protein sequences of ten viral candidates were retrieved from the UniProt database and evaluated for antigenicity using the VaxiJen server. Five highly antigenic proteins derived from Human Cytomegalovirus (HCMV), Human Papillomavirus (HPV), Human Herpesvirus 8 (HHV-8), Human Immunodeficiency Virus (HIV), and Epstein–Barr Virus (EBV) were selected. T cell (CTL and HTL) and B cell (LBL) epitopes were predicted and screened for immunogenicity, allergenicity, and toxicity. The final vaccine construct incorporated β-defensin as an adjuvant and included 3 HTL, 8 CTL, and 8 LBL epitopes. Molecular docking and molecular dynamics (MD) simulations were conducted to assess the binding affinity of the vaccine with Toll-like receptor 3 (TLR3). In silico cloning was also performed using the pET-28a(+) vector in Escherichia coli strain K12.Results: The designed vaccine was found to be antigenic, non-allergenic, and non-toxic. Molecular docking revealed strong binding affinity between the vaccine construct and TLR3, which was further supported by MD simulation results indicating stable complex formation. Codon optimization and in silico cloning confirmed the high expression potential of the vaccine in the E. coli expression system.Discussion: The in silico analyses suggest that the developed multi-epitope vaccine construct is a promising candidate for preventing EC associated with viral infections. While these findings are encouraging, further experimental validation through in vitro and in vivo studies is essential to confirm the vaccine's safety, immunogenicity, and protective efficacy.
- 8 July 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1587224
Open AccessImmuno-informatics analyses of important esophageal cancer associated viruses for multi-epitope vaccine design
Introduction: Esophageal cancer (EC) is a highly lethal malignancy characterized by the uncontrolled proliferation of cancerous cells within the esophagus. Despite recent advancements in therapeutic strategies, the prognosis remains poor, underscoring the urgent need for novel preventive and therapeutic approaches. Notably, several oncogenic viruses have been implicated in EC pathogenesis, prompting the exploration of epitope-based vaccines through immunoinformatics.Methods: Using immunoinformatics and bioinformatics approaches, we designed a novel multi-epitope vaccine targeting viral agents associated with EC. Protein sequences of ten viral candidates were retrieved from the UniProt database and evaluated for antigenicity using the VaxiJen server. Five highly antigenic proteins derived from Human Cytomegalovirus (HCMV), Human Papillomavirus (HPV), Human Herpesvirus 8 (HHV-8), Human Immunodeficiency Virus (HIV), and Epstein–Barr Virus (EBV) were selected. T cell (CTL and HTL) and B cell (LBL) epitopes were predicted and screened for immunogenicity, allergenicity, and toxicity. The final vaccine construct incorporated β-defensin as an adjuvant and included 3 HTL, 8 CTL, and 8 LBL epitopes. Molecular docking and molecular dynamics (MD) simulations were conducted to assess the binding affinity of the vaccine with Toll-like receptor 3 (TLR3). In silico cloning was also performed using the pET-28a(+) vector in Escherichia coli strain K12.Results: The designed vaccine was found to be antigenic, non-allergenic, and non-toxic. Molecular docking revealed strong binding affinity between the vaccine construct and TLR3, which was further supported by MD simulation results indicating stable complex formation. Codon optimization and in silico cloning confirmed the high expression potential of the vaccine in the E. coli expression system.Discussion: The in silico analyses suggest that the developed multi-epitope vaccine construct is a promising candidate for preventing EC associated with viral infections. While these findings are encouraging, further experimental validation through in vitro and in vivo studies is essential to confirm the vaccine's safety, immunogenicity, and protective efficacy.
- Open Access
Machine Learning-Based Virtual Screening and Molecular Modeling Reveal Potential Natural Inhibitors for Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) is the most typical kind of lung cancer. Chemotherapy, radiation therapy, and other traditional cancer therapies are ineffective. Advancements in understanding cancer’s molecular causes have led to targeted therapies, such as those addressing NTRK gene fusions in NSCLC. Several machine-learning techniques were used in our work, including k-Nearest Neighbors (kNN), Support Vector Machine (SVM), Random Forest (RF), and Naive Bayes (NB). As a result, the RF model outperformed the other studied machine-learning methods, achieving an astonishing 93.12% accuracy for both training as well as testing datasets, and it was employed to screen 9000 chemicals, resulting in the discovery of 65 putative NTRK potential inhibitors. The active sites of NTRK proteins were then docked with these 65 active chemicals. Our findings show that Gancaonin X, 5-hydroxy-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one, (2S)-7-[[(2R)-3,3-dimethyloxiran-2-yl]methoxy]-5-hydroxy-2-phenyl-2,3-dihydrochromen-4-one, (2S)-5-hydroxy-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one, and methyl 2-(methylamino)-5-[(3S)-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-3-yl]benzoate establish strong interactions inside the binding region of NTRK, as a result of which stable complexes are formed. This study employs 100 ns molecular dynamics simulations to investigate the dynamic behavior of phytochemical-NTRK complexes, revealing stable interactions through RMSD, RMSF, Rg, and SASA analyses. The detailed examination of protein–ligand interactions provides crucial atomic-level insights, enhancing our understanding of potential neurotrophic receptor kinase-targeted therapeutic strategies. This highlights their significant ability as NTRK antagonists, giving novel treatment options for NSCLC therapy. To summarize, the application of machine learning in combination with virtual screening in this study not only can discover new NSCLC therapeutics but also highlight new computer approaches in the field of drug discovery.
Open AccessMachine Learning-Based Virtual Screening and Molecular Modeling Reveal Potential Natural Inhibitors for Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) is the most typical kind of lung cancer. Chemotherapy, radiation therapy, and other traditional cancer therapies are ineffective. Advancements in understanding cancer’s molecular causes have led to targeted therapies, such as those addressing NTRK gene fusions in NSCLC. Several machine-learning techniques were used in our work, including k-Nearest Neighbors (kNN), Support Vector Machine (SVM), Random Forest (RF), and Naive Bayes (NB). As a result, the RF model outperformed the other studied machine-learning methods, achieving an astonishing 93.12% accuracy for both training as well as testing datasets, and it was employed to screen 9000 chemicals, resulting in the discovery of 65 putative NTRK potential inhibitors. The active sites of NTRK proteins were then docked with these 65 active chemicals. Our findings show that Gancaonin X, 5-hydroxy-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one, (2S)-7-[[(2R)-3,3-dimethyloxiran-2-yl]methoxy]-5-hydroxy-2-phenyl-2,3-dihydrochromen-4-one, (2S)-5-hydroxy-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydropyrano[2,3-h]chromen-4-one, and methyl 2-(methylamino)-5-[(3S)-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazolin-3-yl]benzoate establish strong interactions inside the binding region of NTRK, as a result of which stable complexes are formed. This study employs 100 ns molecular dynamics simulations to investigate the dynamic behavior of phytochemical-NTRK complexes, revealing stable interactions through RMSD, RMSF, Rg, and SASA analyses. The detailed examination of protein–ligand interactions provides crucial atomic-level insights, enhancing our understanding of potential neurotrophic receptor kinase-targeted therapeutic strategies. This highlights their significant ability as NTRK antagonists, giving novel treatment options for NSCLC therapy. To summarize, the application of machine learning in combination with virtual screening in this study not only can discover new NSCLC therapeutics but also highlight new computer approaches in the field of drug discovery.
- 21 March 2025
- Published by Springer Nature in Acta Parasitologica
- Vol. 70 (2) , 1-12
Therapeutic Effects of Green Synthesized Copper Nanoparticles Against Hydatid Disease Through Inhibiting Inflammation, Oxidative Stress, and Apoptosis
Purpose This study aimed to green synthesized copper nanoparticles (CNP) using Lupinus arcticus extract and assess the protoscolicidal effects and the effectiveness of these nanoparticles in experimental animal settings to combat hydatid cysts. Methods The protoscolicidal properties of CNP were examined in vitro on hydatid cyst PS via the eosin exclusion assay. The in vivo effectiveness of CNP at doses of 20, 40, and 80 mg/kg/day for 28 days on hydatid cyst-infected mice was determined by assessing the number, size, weight of hydatid cysts the gene expression levels of caspase-3, antioxidant (glutathione peroxidase (GPx) and superoxide dismutase (SOD)) and inflammatory cytokines (Interleukin-4 (IL-4), IL-10, and inducible nitric oxide synthase (iNOS)) in the infected mice were also assessed by Real-time PCE. Results Analyses revealed that the CNP had a spherical shape, ranging in size from 10 to 85 nm. The half-maximal inhibitory concentration (IC50) values for CNP against protoscoleces ranged from 39.9 to 341.3 µg/mL. Caspase-3 gene expression in the PS treated with CNP at 1/3 IC50, ½ IC50, and IC50 was 1.79-, 3.11-, and 5.39-fold change (p < 0.001). Upon administration of CNP, particularly at doses of 80 mg/kg, a significant decrease (p < 0.001) in hydatid cysts’ quantity, size, and weight was evident. CNP treatment caused a notable reduction in oxidative stress markers and inflammatory cytokines and increased the gene expression of antioxidant enzymes (p < 0.001), whereas it modulated the serum levels of liver function parameters. Conclusion The study indicated the potential of green-synthesized CNP for eliminating the protoscoleces and in managing hydatid cysts through leveraging its antioxidant and anti-inflammatory characteristics. Nevertheless, additional investigations are necessary to elucidate the precise mechanisms of action and evaluate its effectiveness in clinical trials. Clinical Trial Number Not applicable.
- 21 March 2025
- Published by Springer Nature in Acta Parasitologica
- Vol. 70 (2) , 1-12
Therapeutic Effects of Green Synthesized Copper Nanoparticles Against Hydatid Disease Through Inhibiting Inflammation, Oxidative Stress, and Apoptosis
Purpose This study aimed to green synthesized copper nanoparticles (CNP) using Lupinus arcticus extract and assess the protoscolicidal effects and the effectiveness of these nanoparticles in experimental animal settings to combat hydatid cysts. Methods The protoscolicidal properties of CNP were examined in vitro on hydatid cyst PS via the eosin exclusion assay. The in vivo effectiveness of CNP at doses of 20, 40, and 80 mg/kg/day for 28 days on hydatid cyst-infected mice was determined by assessing the number, size, weight of hydatid cysts the gene expression levels of caspase-3, antioxidant (glutathione peroxidase (GPx) and superoxide dismutase (SOD)) and inflammatory cytokines (Interleukin-4 (IL-4), IL-10, and inducible nitric oxide synthase (iNOS)) in the infected mice were also assessed by Real-time PCE. Results Analyses revealed that the CNP had a spherical shape, ranging in size from 10 to 85 nm. The half-maximal inhibitory concentration (IC50) values for CNP against protoscoleces ranged from 39.9 to 341.3 µg/mL. Caspase-3 gene expression in the PS treated with CNP at 1/3 IC50, ½ IC50, and IC50 was 1.79-, 3.11-, and 5.39-fold change (p < 0.001). Upon administration of CNP, particularly at doses of 80 mg/kg, a significant decrease (p < 0.001) in hydatid cysts’ quantity, size, and weight was evident. CNP treatment caused a notable reduction in oxidative stress markers and inflammatory cytokines and increased the gene expression of antioxidant enzymes (p < 0.001), whereas it modulated the serum levels of liver function parameters. Conclusion The study indicated the potential of green-synthesized CNP for eliminating the protoscoleces and in managing hydatid cysts through leveraging its antioxidant and anti-inflammatory characteristics. Nevertheless, additional investigations are necessary to elucidate the precise mechanisms of action and evaluate its effectiveness in clinical trials. Clinical Trial Number Not applicable.
- 24 January 2025
- Published by Springer Nature in Acta Parasitologica
- Vol. 70 (1) , 1-13
Rhanterium Epapposum Essential Oil and Its Primary Compounds Control Infection, Inflammation, and Serum Electrolyte Imbalance in Mice with Giardiasis
Purpose The present experimental study seeks to evaluate the in vitro and in vivo effects, as well as the potential mechanisms of action, of Rhanterium epapposum essential oil (REE) and its main constituents against Giardia lamblia infection. Methods The analysis of REE was performed using the Gas Chromatography-Mass Spectrometry (GC-MS) detector. The in vitro effects of REE and its main constituents on viability of G. lamblia cysts and the human intestinal epithelial cell line, as well as their effects on plasma membrane permeability, the reactive oxygen species (ROS) generation, and trophozoite adherence were assessed by MTT assay. Effects of oral administration of REE and its main constituents at doses 10 and 20 mg/kg on the number of Giardia cysts, the serum level of electrolytes of sodium (Na+) and potassium (K+), as well as the gene expression of inflammatory genes of TNF-α, IL-1β, IL-10, NF-κB p65, and Toll-like receptor 4 (TLR4)) were assessed. Results The 50% inhibitory concentrations (IC50) value of REE, MC, CP, LN and MTZ against G. lamblia cysts was 26.7, 32.1, 35.3, 45.1, and 42.1 µg/mL, respectively; indicated that REE, MC, and CP displayed high antigiardial effects in comparison with MTZ. The obtained 50% cytotoxic concentration (CC50) value of REE, MC, CP, LN, and MTZ on HIEC-6 cells was 279.1, 363.4, 394.2, 478.3, and 422.1 µg/mL, respectively. REE and its main compounds significantly (p < 0.001) increased the plasma membrane permeability and ROS generation in Giardia trophozoites, while, reduced the Giardia trophozoites adherence. In vivo, REE, MC, CP, and LN mainly at the dose of 20 mg/kg considerably reduced the number and viability of Giardia cysts, modulated the serum level of electrolytes Na and K in the infected mice compared with the mice treated with MTZ (P < 0.01); whereas inhibited the inflammation cytokines in the infected mice compared with the mice treated with MTZ (p < 0.001). Conclusion The current investigation showed that R. epapposum essential oil and its main compounds controlled the Giardia infection in mice by inhibiting inflammation, and serum electrolyte imbalance. After confirmation in further studies, these compounds may be considered for development as a novel therapeutic option for the treatment of giardiasis.
- 24 January 2025
- Published by Springer Nature in Acta Parasitologica
- Vol. 70 (1) , 1-13
Rhanterium Epapposum Essential Oil and Its Primary Compounds Control Infection, Inflammation, and Serum Electrolyte Imbalance in Mice with Giardiasis
Purpose The present experimental study seeks to evaluate the in vitro and in vivo effects, as well as the potential mechanisms of action, of Rhanterium epapposum essential oil (REE) and its main constituents against Giardia lamblia infection. Methods The analysis of REE was performed using the Gas Chromatography-Mass Spectrometry (GC-MS) detector. The in vitro effects of REE and its main constituents on viability of G. lamblia cysts and the human intestinal epithelial cell line, as well as their effects on plasma membrane permeability, the reactive oxygen species (ROS) generation, and trophozoite adherence were assessed by MTT assay. Effects of oral administration of REE and its main constituents at doses 10 and 20 mg/kg on the number of Giardia cysts, the serum level of electrolytes of sodium (Na+) and potassium (K+), as well as the gene expression of inflammatory genes of TNF-α, IL-1β, IL-10, NF-κB p65, and Toll-like receptor 4 (TLR4)) were assessed. Results The 50% inhibitory concentrations (IC50) value of REE, MC, CP, LN and MTZ against G. lamblia cysts was 26.7, 32.1, 35.3, 45.1, and 42.1 µg/mL, respectively; indicated that REE, MC, and CP displayed high antigiardial effects in comparison with MTZ. The obtained 50% cytotoxic concentration (CC50) value of REE, MC, CP, LN, and MTZ on HIEC-6 cells was 279.1, 363.4, 394.2, 478.3, and 422.1 µg/mL, respectively. REE and its main compounds significantly (p < 0.001) increased the plasma membrane permeability and ROS generation in Giardia trophozoites, while, reduced the Giardia trophozoites adherence. In vivo, REE, MC, CP, and LN mainly at the dose of 20 mg/kg considerably reduced the number and viability of Giardia cysts, modulated the serum level of electrolytes Na and K in the infected mice compared with the mice treated with MTZ (P < 0.01); whereas inhibited the inflammation cytokines in the infected mice compared with the mice treated with MTZ (p < 0.001). Conclusion The current investigation showed that R. epapposum essential oil and its main compounds controlled the Giardia infection in mice by inhibiting inflammation, and serum electrolyte imbalance. After confirmation in further studies, these compounds may be considered for development as a novel therapeutic option for the treatment of giardiasis.
- Open Access
Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives
A new series of thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines was designed and synthesized using readily available starting materials, specifically, β-enaminoester. Their cytotoxicity was screened against three cancer cell lines, namely, MCF-7, HCT-116, and PC-3. 2-(4-bromophenyl)triazole 10b and 2-(anthracen-9-yl)triazole 10e afforded excellent potency against MCF-7 cell lines (IC50 = 19.4 ± 0.22 and 14.5 ± 0.30 μM, respectively) compared with doxorubicin (IC50 = 40.0 ± 3.9 μM). The latter derivatives 10b and 10e were further subjected to in silico ADME and docking simulation studies against EGFR and PI3K and could serve as ideal leads for additional modification in the field of anticancer research.
Open AccessDesigning Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives
A new series of thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines was designed and synthesized using readily available starting materials, specifically, β-enaminoester. Their cytotoxicity was screened against three cancer cell lines, namely, MCF-7, HCT-116, and PC-3. 2-(4-bromophenyl)triazole 10b and 2-(anthracen-9-yl)triazole 10e afforded excellent potency against MCF-7 cell lines (IC50 = 19.4 ± 0.22 and 14.5 ± 0.30 μM, respectively) compared with doxorubicin (IC50 = 40.0 ± 3.9 μM). The latter derivatives 10b and 10e were further subjected to in silico ADME and docking simulation studies against EGFR and PI3K and could serve as ideal leads for additional modification in the field of anticancer research.
- Open Access
- 1 September 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (9) , 101732
Exploring the multi-gene regulatory molecular mechanism of Saudi Arabian flora against epilepsy based on data mining, network pharmacology and docking analysis
Epilepsy is a chronic neurological disorder marked by recurrent seizures, significantly affecting the population in Saudi Arabia across all age demographics. The global prevalence of active epilepsy is around 6.38/1,000 persons and in the Arabian region, the median prevalence of active epilepsy is 4.4/1,000 persons. However, over 75% of individuals are untreated. Consequently, the development of therapeutic strategies with increased efficacy and safety profiles is essential to improve the survival rate among epilepsy patients. The current study integrates network pharmacology along with Bioinformatics approaches to explore the potential molecular mechanisms of local flora of Saudi Arabia including Solanum incanum, Abrus precatorius, Withania somnifera, and Azadirachta indica in epilepsy treatment. In the preliminary phase, data related to the bioactive components of the local plants and the associated target genes of both these plants and epilepsy were gathered from scientific literature and open-source databases. This data was then analyzed to identify common targets between the plants and ovarian cancer. Based on these common targets, a protein–protein interaction (PPI) network was constructed utilizing the STRING database, which was subsequently incorporated into the Cytoscape software for identification of hub genes based on their degree of connectivity. Lastly, an interplay network depicting the associations between the compounds and the overlapping genes was formulated via Cytoscape, to study the potential network pharmacology implications of these active compounds in relation to ovarian cancer. Following that, a compound-target protein-pathway network was constructed which uncovered that namely abrectorin, genistin, (+)-catechin, precatorine, (+)-ascorbic acid, licoflavanone, skrofulein, stigmasterone, 5,7-Dihydroxy-4′-methoxy-8,3′-di-C-prenylflavanone could potentially be used as antagonists for the therapeutic management of epilepsy by targeting TNF and TP53 proteins. Furthermore, the implementation of molecular docking reinforces the binding affinity of the compound, indicating a robust stability of the forecasted compounds at the docked site. This research lays both a theoretical and experimental groundwork for more profound investigations and establishes a practical method for the strategic employment of active compounds in the development of anti-epileptic therapeutics.
- 1 September 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (9) , 101732
Open AccessExploring the multi-gene regulatory molecular mechanism of Saudi Arabian flora against epilepsy based on data mining, network pharmacology and docking analysis
Epilepsy is a chronic neurological disorder marked by recurrent seizures, significantly affecting the population in Saudi Arabia across all age demographics. The global prevalence of active epilepsy is around 6.38/1,000 persons and in the Arabian region, the median prevalence of active epilepsy is 4.4/1,000 persons. However, over 75% of individuals are untreated. Consequently, the development of therapeutic strategies with increased efficacy and safety profiles is essential to improve the survival rate among epilepsy patients. The current study integrates network pharmacology along with Bioinformatics approaches to explore the potential molecular mechanisms of local flora of Saudi Arabia including Solanum incanum, Abrus precatorius, Withania somnifera, and Azadirachta indica in epilepsy treatment. In the preliminary phase, data related to the bioactive components of the local plants and the associated target genes of both these plants and epilepsy were gathered from scientific literature and open-source databases. This data was then analyzed to identify common targets between the plants and ovarian cancer. Based on these common targets, a protein–protein interaction (PPI) network was constructed utilizing the STRING database, which was subsequently incorporated into the Cytoscape software for identification of hub genes based on their degree of connectivity. Lastly, an interplay network depicting the associations between the compounds and the overlapping genes was formulated via Cytoscape, to study the potential network pharmacology implications of these active compounds in relation to ovarian cancer. Following that, a compound-target protein-pathway network was constructed which uncovered that namely abrectorin, genistin, (+)-catechin, precatorine, (+)-ascorbic acid, licoflavanone, skrofulein, stigmasterone, 5,7-Dihydroxy-4′-methoxy-8,3′-di-C-prenylflavanone could potentially be used as antagonists for the therapeutic management of epilepsy by targeting TNF and TP53 proteins. Furthermore, the implementation of molecular docking reinforces the binding affinity of the compound, indicating a robust stability of the forecasted compounds at the docked site. This research lays both a theoretical and experimental groundwork for more profound investigations and establishes a practical method for the strategic employment of active compounds in the development of anti-epileptic therapeutics.